Standout Papers

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease 2020 2026 2022 2024206
  1. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease (2020)
    Martí Colom‐Cadena, Tara L. Spires‐Jones et al. Alzheimer s Research & Therapy

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
2024 Standout
Improving prime editing with an endogenous small RNA-binding protein
2024 StandoutNature
6 intermediate papers

Works of Martí Colom‐Cadena being referenced

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
2017
Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Martí Colom‐Cadena 724 382 245 269 20 1.0k
Karolien Bettens 830 606 188 313 24 1.4k
Janusz Frackowiak 880 458 161 318 42 1.3k
Isabel Costantino 725 328 219 310 11 1.1k
Martin C. Herzig 1010 470 276 366 17 1.4k
Marc Vandermeeren 764 516 221 194 20 1.2k
Michael W. DeLucia 874 336 205 290 11 1.2k
Olivia Belbin 848 536 168 255 49 1.4k
Ellen J. Steinbart 725 460 242 255 28 1.2k
John F. Ervin 536 378 236 190 26 1.0k
Marianne Hallupp 717 669 301 233 25 1.3k

All Works

Loading papers...

Rankless by CCL
2026